153 related articles for article (PubMed ID: 37227155)
21. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
22. In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.
Wang M; Liu G; Shan GP; Wang BB
Cancer Biother Radiopharm; 2017 Aug; 32(6):193-203. PubMed ID: 28820634
[TBL] [Abstract][Full Text] [Related]
23. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
Yi X; Wang Y; Xu S
J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma.
Jin Y; Li L; Zhu T; Liu G
Pathol Res Pract; 2019 Dec; 215(12):152688. PubMed ID: 31727503
[TBL] [Abstract][Full Text] [Related]
25. Shift in G
Li F; Mladenov E; Dueva R; Stuschke M; Timmermann B; Iliakis G
Cells; 2021 Dec; 11(1):. PubMed ID: 35011623
[TBL] [Abstract][Full Text] [Related]
26. Upregulated miRNA-1236-3p in osteosarcoma inhibits cell proliferation and induces apoptosis via targeting KLF8.
Sun Y; Cao L; Lin JT; Yuan Y; Cao ZL; Jia JD
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6053-6061. PubMed ID: 31364106
[TBL] [Abstract][Full Text] [Related]
27. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J
Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728
[No Abstract] [Full Text] [Related]
28. Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma.
Baranski Z; Booij TH; Cleton-Jansen AM; Price LS; van de Water B; Bovée JV; Hogendoorn PC; Danen EH
J Pathol; 2015 Jul; 236(3):348-59. PubMed ID: 25757065
[TBL] [Abstract][Full Text] [Related]
29. Contribution of ATM and ATR to the resistance of glioblastoma and malignant melanoma cells to the methylating anticancer drug temozolomide.
Eich M; Roos WP; Nikolova T; Kaina B
Mol Cancer Ther; 2013 Nov; 12(11):2529-40. PubMed ID: 23960094
[TBL] [Abstract][Full Text] [Related]
30. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
31. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
32. miR-5195-3p Suppresses Cell Proliferation and Induces Apoptosis by Directly Targeting NEDD9 in Osteosarcoma.
Wang L; Shi G; Zhu D; Jin Y; Yang X
Cancer Biother Radiopharm; 2019 Aug; 34(6):405-412. PubMed ID: 31411930
[No Abstract] [Full Text] [Related]
33. miR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16.
Gao S; Wang J; Tian S; Luo J
Int J Oncol; 2019 Jun; 54(6):1921-1932. PubMed ID: 31081054
[TBL] [Abstract][Full Text] [Related]
34. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
Lian H; Xie P; Yin N; Zhang J; Zhang X; Li J; Zhang C
Life Sci; 2019 Sep; 233():116757. PubMed ID: 31419446
[TBL] [Abstract][Full Text] [Related]
35. The novel quinolone CHM-1 induces DNA damage and inhibits DNA repair gene expressions in a human osterogenic sarcoma cell line.
Chen HY; Lu HF; Yang JS; Kuo SC; Lo C; Yang MD; Chiu TH; Chueh FS; Ho HC; Ko YC; Chung JG
Anticancer Res; 2010 Oct; 30(10):4187-92. PubMed ID: 21036739
[TBL] [Abstract][Full Text] [Related]
36. FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.
Habel N; El-Hachem N; Soysouvanh F; Hadhiri-Bzioueche H; Giuliano S; Nguyen S; Horák P; Gay AS; Debayle D; Nottet N; Béranger G; Paillerets BB; Bertolotto C; Ballotti R
Cell Death Differ; 2021 Jun; 28(6):1837-1848. PubMed ID: 33462405
[TBL] [Abstract][Full Text] [Related]
37. Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
Lee B; Lee HJ; Cho HY; Suh DH; Kim K; No JH; Kim H; Kim YB
Anticancer Res; 2015 Jul; 35(7):3909-16. PubMed ID: 26124337
[TBL] [Abstract][Full Text] [Related]
38. Circ_0001174 facilitates osteosarcoma cell proliferation, migration, and invasion by targeting the miR-186-5p/MACC1 axis.
Lin F; Wang X; Zhao X; Ren M; Wang Q; Wang J
J Orthop Surg Res; 2022 Mar; 17(1):159. PubMed ID: 35279159
[TBL] [Abstract][Full Text] [Related]
39. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
40. Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell.
Wang JY; Chen CM; Chen CF; Wu PK; Chen WM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]